US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist
  • 0.674
  • -0.086-11.37%
Close Dec 13 16:00 ET
  • 0.700
  • +0.026+3.86%
Post 20:01 ET
196.86MMarket Cap-0.85P/E (TTM)

Lyell Immunopharma Key Stats

Lyell Immunopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q334.000K / 0.000--
--2024/Q213.000K / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q334.000K / 0.000--
--2024/Q213.000K / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Lyell Immunopharma Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 15, 2024

Hold

  • Buy

    0.00%
  • Hold

    100.00%
  • Sell

    0.00%

Price Target

No Data